Kratom
-
CDC: U.S. kava exposures rise to 203 in 2025 as kratom co-use drives severe outcomes
New CDC findings reveal a surge in kava-related exposures in the U.S., with co-use of kratom linked to more serious health outcomes. The report contrasts traditional Pacific use with commercial products and raises questions about safety, regulation, and impact on Pacific exporters.